(E)-N-[3-(2-bromo-4-fluorophenyl)-2-oxopiperidin-1-yl]-3-[3-methoxy-4-(4-methyl-1H-imidazol-1-yl)phenyl]acrylamide
(E)-N-[3-(2-溴-4-氟苯基)-2-氧代哌啶-1-基]-3-[3-甲氧基-4-(4-甲基-1H-咪唑-1-基)苯基]丙烯酰胺
(E)-N-[3-(2-bromo-4-fluorophenyl)-2-oxopiperidin-1-yl]-3-[3-methoxy-4-(4-methyl-1H-imidazol-1-yl)phenyl]acrylamide (CAS 949168-36-9) is a compound in the Pharma Intermediates category listed in the Jingsj chemical database. It has the molecular formula C25H24BrFN4O3 and a molecular weight of 527.4 g/mol. No supplier offers are currently listed; request a quote. Record last updated Aug 21, 2026.
- CAS No.
- 949168-36-9
- Jingsj CID
- J-447889-0
- Molecular Formula
- C25H24BrFN4O3
- Chinese Name
- (E)-N-[3-(2-溴-4-氟苯基)-2-氧代哌啶-1-基]-3-[3-甲氧基-4-(4-甲基-1H-咪唑-1-基)苯基]丙烯酰胺
- Molecular Weight
- 527.4 g/mol
- Category
- Pharma Intermediates
- Last updated
- 8/21/2026
No offers for this compound yet.
Request a quoteFrequently Asked Questions
What is the CAS number of (E)-N-[3-(2-bromo-4-fluorophenyl)-2-oxopiperidin-1-yl]-3-[3-methoxy-4-(4-methyl-1H-imidazol-1-yl)phenyl]acrylamide?
The CAS number of (E)-N-[3-(2-bromo-4-fluorophenyl)-2-oxopiperidin-1-yl]-3-[3-methoxy-4-(4-methyl-1H-imidazol-1-yl)phenyl]acrylamide is 949168-36-9.
What are the molecular formula and molecular weight of (E)-N-[3-(2-bromo-4-fluorophenyl)-2-oxopiperidin-1-yl]-3-[3-methoxy-4-(4-methyl-1H-imidazol-1-yl)phenyl]acrylamide?
(E)-N-[3-(2-bromo-4-fluorophenyl)-2-oxopiperidin-1-yl]-3-[3-methoxy-4-(4-methyl-1H-imidazol-1-yl)phenyl]acrylamide has molecular formula C25H24BrFN4O3 and molecular weight 527.4 g/mol.
Data compiled from public chemical databases and supplier catalogs; supplier offers are provided by suppliers.
Last updated:
How to cite: Jingsj. "(E)-N-[3-(2-bromo-4-fluorophenyl)-2-oxopiperidin-1-yl]-3-[3-methoxy-4-(4-methyl-1H-imidazol-1-yl)phenyl]acrylamide (CAS 949168-36-9)". Jingsj Chemical Database. https://www.jingsj.com/compound/J-447889-0 (accessed 2026-10-23).
Data for reference only; verify specifications, grades and regulatory status with suppliers before purchase.